|
KMID : 0613820070170040515
|
|
Journal of Life Science
2007 Volume.17 No. 4 p.515 ~ p.521
|
|
|
Effect of Low Dose Administration of Aprotinin in Pump Priming Solution on Cardiac Surgery
|
|
Moon Sung-Min
Choi Seok-Cheol
|
|
|
Abstract
|
|
|
|
Aprotinin, a serine protease inhibitor, has been used to ameliorate the inevitable consequences, including blood component injury after cardiac surgery with cardiopulmonary bypass (CPB). However, there are many arguments on its dosage or usage. We assessed whether administration of low dose of aprotinin in only priming solution has any beneficial effect or reduces its side effects on cardiac surgery. Thirty patients scheduled for elective cardiac surgery were randomly assigned to aprotinin group (n=15) which received aprotinin in priming solution (two million kallikrein inhibitory unit, KIU) and added one million KIU at 1 hour after the beginning of CPB or control group (n=15) which did not receive it. Hematological and biochemical variables, cytokines and cardiac marker levels, and postoperative outcomes were compared between two groups at before, during or after operation. Platelet count in aprotinin group was higher than that of control group at postoperative 24 hr. Activated partial thromboplastin time in aprotinin group was longer than that of control group at intensive care unit (ICU). Troponin-I level and postoperative blood loss volumes in aprotinin group were lower than those of control group at ICU. There were no significant differences between the two groups on the others. These results showed that low dosage of only priming solution during cardiac surgery with CPB reduced platelet destruction and postoperative bleeding, and attenuates myocardial damage. However, further studies need to be carried out with more population or pediatric patients for evaluating various aprotinin usage.
|
|
|
KEYWORD
|
|
|
Cardiac surgery, cardiopulmonary bypass, aprotinin
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|